-
News | 2020.10.12
A feedback on 10 months of mobilization of the Institut Pasteur against covid-19
On Thursday, October 8, 2020, the Institut Pasteur in Paris organized an exceptional digital conference to review 10 months of mobilization against Covid-19, a force still in action for global health. Four experts from the Institut Pasteur were present to talk about the epidemic, tests, treatments, vaccines, scientific modelling, and answer questions from Internet users. This conference is...
-
News | 2020.11.02
New Edition Of The Free On-Line Mooc Tuberculosis
Tuberculosis (TB) remains one of the ten leading causes of death worldwide and the biggest killer among infectious diseases, surpassing even AIDS and malaria. Although it is hoped that TB can be eliminated within the next couple of decades, the incidence is currently falling by only 1.5% per year. Each year there are about 10 million new cases of TB and a half a million of these are multi-drug...
-
News | 2021.11.10
COVID-19: Kamala Harris, Vice President of the United States, salutes the Institut Pasteur's response in tackling the pandemic
As part of her trip to France for the fourth Paris Peace Forum – which includes three round tables on the challenges raised by the COVID-19 pandemic –, Kamala Harris, Vice President of the United States, visited the Institut Pasteur on November 9, 2021. She met several of the Institut Pasteur's scientists and saluted the unprecedented response of the Institut Pasteur's scientific community in...
-
Fiche maladie | 2021.07.07
Buruli Ulcer
Buruli ulcer is a disease caused by a bacterium that multiplies in skin and is currently reported in 33 countries, mostly in tropical regions. Although not fatal, it can lead to permanent disabilities, imposing a heavy burden on both patients and society.
-
Document de presse | 2005.04.18
Newborn susceptibility to infection now deciphered
A joint Institut Pasteur-Inserm team has deciphered key mechanisms in the development of newborn immune systems. This study has made it possible to understand why infants are susceptible to early infections that cause high mortality rates, particularly in developing countries. Understanding these mechanisms offers possibilities for new types of treatment and vaccines adapted to protect newborns...
-
News | 2016.12.01
Hepatitis B may infect twice more African babies than HIV
The number of newborns infected with Hepatitis B may be twice as high as HIV in sub-Saharan Africa.While the risk of mother-to-child transmission of Hepatitis B is well documented in Asia, data regarding the situation in Africa are still scarce. In an article published in the Alimentary Pharmacology & Therapeutics journal, Epidemiologists from Institut Pasteur, Ecole Pasteur/CNAM de Santé...
-
News | 2016.08.10
Disturbing prevalence of antibiotic-resistant Enterobacteriaceae in Central African children
Nearly 59% of Central African children under 5 years, are asymptomatic carriers of extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBL-E); one of the highest prevalence ever described in the world. These bacteria are resistant to every antibiotics currently marketed in Central African Republic.Alain Farra, Thierry Frank and Sébastien Breurec (1), from Bacteriology Laboratory at the...
-
Fiche maladie | 2015.10.06
Leishmaniasis
Leishmaniasis is a parasitic disease that causes severely debilitating cutaneous or visceral lesions, which can be fatal if left untreated. The plural form "leishmaniases" is sometimes used, as the disease is actually a group of diseases caused by different parasites of the genus Leishmania, transmitted by the bites of sandflies. These parasitic diseases are considered emerging neglected diseases...
-
News | 2021.02.08
Antibiotic response in bacteria: the role of membrane vesicles
Membrane vesicles (also known as extracellular vesicles) are produced by all kinds of organisms. They are small lipid bags that come off a donor cell and get internalized by a recipient cell. Their role is to carry biological information and they are described as key intercellular communication players. However, their role in the microbial world is still very much unknown. Researchers from the...
-
Document de presse | 2021.08.19
Immune checkpoint inhibitors improve cellular immunity against SARS-CoV-2
Researchers and doctors from the AP-HP, the Institut Pasteur, the University of Paris and the Sorbonne University, have carried out work on the effect of immune checkpoint inhibitors (anti-PD1 and anti-CTLA4) on cellular immunity against SARS-CoV-2. This work, the results of which suggest that these treatments are not deleterious during infection with COVID-19 and, on the contrary, seem to...